Your browser doesn't support javascript.
loading
Low molecular weight heparin for the prevention of severe preeclampsia: where next?
McLaughlin, Kelsey; Scholten, Ralph R; Parker, John D; Ferrazzi, Enrico; Kingdom, John C P.
Afiliación
  • McLaughlin K; The Centre for Women's and Infant's Health at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Canada.
  • Scholten RR; Department of Medicine, Division of Cardiology, Sinai Health System, University of Toronto, Canada.
  • Parker JD; Department of Obstetrics and Gynaecology, Division of Maternal-Fetal Medicine, Sinai Health System, University of Toronto, Canada.
  • Ferrazzi E; Department of Medicine, Division of Cardiology, Sinai Health System, University of Toronto, Canada.
  • Kingdom JCP; Department of Obstetrics and Gynaecology, Buzzi Children's Hospital, University of Milan, Italy.
Br J Clin Pharmacol ; 84(4): 673-678, 2018 04.
Article en En | MEDLINE | ID: mdl-29226532
ABSTRACT
Low molecular weight heparin has been extensively evaluated for the prevention of preeclampsia in high-risk pregnant women; however, the results from these trials have been conflicting. This review discusses the potential mechanisms of action of low molecular weight heparin for the prevention of severe preeclampsia, how to optimize the selection of high-risk women for participation in future trials, and the importance of trial standardization.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preeclampsia / Heparina de Bajo-Peso-Molecular / Anticoagulantes Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Br J Clin Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preeclampsia / Heparina de Bajo-Peso-Molecular / Anticoagulantes Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Br J Clin Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Canadá